---
aliases:
  - HSCT
  - bone marrow transplant
---
A hematopoietic stem cell transplant (HSCT), also known as a bone marrow transplant, is a medical procedure used to replace damaged or destroyed bone marrow with healthy hematopoietic stem cells. These stem cells are the precursors to [[acute lymphoblastic leukemia]] [[Blood]] cells, including red [[Blood]] cells, white [[Blood]] cells, and platelets. HSCT is a treatment option for various [[Blood]] disorders, cancers, and some autoimmune diseases.

### Types of Hematopoietic Stem Cell Transplants:
1. **Autologous Stem Cell Transplant:**
   - **Definition:** In this type, the patient's own stem cells are collected, stored, and then reinfused after intensive treatment (like chemotherapy) that destroys the diseased bone marrow.
   - **Uses:** Often used for conditions like multiple [[myeloma]], Hodgkin [[Lymphoma]], and non-Hodgkin [[Lymphoma]].

2. **Allogeneic Stem Cell Transplant:**
   - **Definition:** Stem cells are taken from a donor, either related (like a sibling) or unrelated, whose tissue type closely matches the patient’s.
   - **Uses:** Commonly used for conditions such as [[Leukemia]], [[aplastic anemia]], and certain genetic disorders.
   - **Considerations:** Graft-versus-host disease ([[GVHD]]) is a potential complication, where the donor cells attack the recipient’s tissues.

3. **Syngeneic Stem Cell Transplant:**
   - **Definition:** This involves stem cells from an identical twin, which are genetically identical to the patient's.
   - **Uses:** Similar to allogeneic transplants but with a lower risk of complications like [[GVHD]].

### Indications for Hematopoietic Stem Cell Transplant:
- **Hematologic Cancers:** Including [[Leukemia]] (acute myeloid [[Leukemia]], chronic myeloid [[Leukemia]], [[acute lymphoblastic leukemia]]), [[Lymphoma]] (Hodgkin and non-Hodgkin), and multiple [[myeloma]].
- **Bone Marrow Failure Syndromes:** Such as [[aplastic anemia]] and myelodysplastic syndromes.
- **Inherited [[Blood]] Disorders:** Like thalassemia, sickle cell disease, and certain immune deficiencies.
- **Autoimmune Diseases:** In some cases, HSCT is used for severe, refractory autoimmune diseases like multiple sclerosis or [[systemic lupus erythematosus]].

### The Transplant Process:
1. **Pre-Transplant Conditioning:** 
   - Patients typically undergo high-dose chemotherapy, radiation, or a combination (called conditioning) to destroy their diseased bone marrow and suppress their immune system to prevent rejection of the transplanted cells.

2. **Stem Cell Infusion:**
   - The healthy stem cells are infused into the patient's bloodstream through an intravenous (IV) line, much like a [[Blood]] transfusion. These cells travel to the bone marrow, where they begin to produce new [[Blood]] cells.

3. **Engraftment:**
   - Engraftment is the process by which the transplanted stem cells begin to grow and produce new [[Blood]] cells. This usually occurs within 2-4 weeks post-transplant.

4. **Post-Transplant Care:**
   - Patients require close monitoring for complications like infections (due to immunosuppression), [[GVHD]] (in allogeneic transplants), and organ toxicity. They may also receive medications to prevent infection and manage any side effects.

### Complications and Risks:
- **Graft-Versus-Host Disease ([[GVHD]]):** A significant risk in allogeneic transplants, where the donor's immune cells attack the recipient's tissues, leading to symptoms ranging from mild to life-threatening.
- **Infections:** Due to the weakened immune system, patients are highly susceptible to infections until the new immune system is fully functional.
- **Graft Failure:** A rare but serious complication where the transplanted stem cells do not produce new [[Blood]] cells.
- **Organ Damage:** Conditioning regimens can cause damage to organs like the [[Liver]], lungs, or [[Heart]].
- **Long-Term Risks:** Secondary cancers and [[infertility]] are potential long-term risks associated with HSCT.

### Outcomes and Prognosis:
- The success of an HSCT depends on various factors, including the patient’s underlying condition, age, overall health, the type of transplant, and how well the body accepts the new stem cells.
- Advances in HSCT, including better matching techniques, improved supportive care, and new therapies for [[GVHD]], have significantly improved outcomes over the years.

### Living After HSCT:
- Recovery from HSCT is a long process, often taking months to a year. Patients may need to make lifestyle changes and undergo regular follow-up care to monitor for complications and ensure the success of the transplant.
- Quality of life generally improves over time, and many patients go on to lead healthy, active lives post-transplant.

HSCT is a complex procedure with significant risks, but for many patients, it offers the potential for cure or long-term remission from life-threatening conditions.